No abstract available
Keywords:
Acute cardiac care; Acute coronary syndromes; Angioplasty; Anticoagulation; Apixaban; Aspirin; Atherothrombosis; Beta-blockers; Bivalirudin; Bypass surgery; Cangrelor; Chest pain unit; Clopidogrel; Dabigatran; Diabetes; Early invasive strategy; Enoxaparin; European Society of Cardiology; Fondaparinux; Glycoprotein IIb/IIIa inhibitors; Guidelines; Heparin; High-sensitivity troponin; Myocardial ischaemia; Nitrates; Non-ST-elevation myocardial infarction; Platelet inhibition; Prasugrel; Recommendations; Revascularization; Rhythm monitoring; Rivaroxaban; Statin; Stent; Ticagrelor; Unstable angina; Vorapaxar.
MeSH terms
-
Acute Coronary Syndrome / diagnosis
-
Acute Coronary Syndrome / therapy*
-
Algorithms
-
Angina Pectoris / etiology
-
Anticoagulants / therapeutic use
-
Biomarkers / metabolism
-
Cardiotonic Agents / therapeutic use
-
Coronary Angiography / methods
-
Diagnosis, Differential
-
Electrocardiography
-
Hemorrhage / prevention & control
-
Humans
-
Long-Term Care
-
Non-ST Elevated Myocardial Infarction / diagnosis
-
Non-ST Elevated Myocardial Infarction / therapy*
-
Percutaneous Coronary Intervention / methods
-
Physical Examination / methods
-
Platelet Aggregation Inhibitors / therapeutic use
-
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
-
Purinergic P2Y Receptor Antagonists / therapeutic use
-
Risk Assessment / methods
Substances
-
Anticoagulants
-
Biomarkers
-
Cardiotonic Agents
-
Platelet Aggregation Inhibitors
-
Platelet Glycoprotein GPIIb-IIIa Complex
-
Purinergic P2Y Receptor Antagonists